Search Climate Insights Directory

The report details a strategic scenario for Africa to improve health and demographic outcomes by 2050. Key interventions include increasing modern contraceptive use to 75% in sub-Saharan Africa and 85% in North Africa, reducing mortality for the top five disease types by 20 percentage points, and expanding safely managed water and sanitation access. The scenario also targets a 20% reduction in under-five stunting in 39 countries. These improvements require an additional US$18.9 billion in health spending continentwide, with infrastructure spending peaking at US$4.7 billion per annum in 2037. The model is based on empirical benchmarks from countries like Ethiopia, Malawi, Ghana, and Kenya, and mirrors historical progress in South America and South Asia.

Mexico's Directorate-General for Climate Action Policies confirms its alignment with the LAC Common Position on Climate Change and Health, detailing how its Nationally Determined Contribution (NDC) 3.0 integrates health as a cross-cutting issue across adaptation, mitigation, and loss and damage components.

The analysis of the FY26 Presidential Budget Request indicates a general decline in biodefense and biosecurity funding across the US government, despite an overall increase in the Department of Defense budget. Significant cuts are observed in the CDC, NIH, and Department of State, while the Department of Homeland Security has undergone a major reorganization of its biodefense functions. The report argues that these reductions in vaccine R&D and global threat reduction efforts undermine US leadership and its ability to deter biological weapons.

The document outlines how climate change increases the prevalence of climate-sensitive diseases and strains healthcare infrastructure, particularly in vulnerable border communities and among migrant populations.

The Council on Strategic Risks and Lawrence Berkeley National Laboratory propose a series of strategic actions to strengthen the United States' biomanufacturing capabilities for pandemic preparedness. Key recommendations include executing existing national biosecurity strategies, using federal procurement to create sustainable industry demand, leveraging the Defense Production Act and FDA processes, and establishing an Interagency Working Group on Biomanufacturing. The plan also emphasizes the need for improved pathogen early warning data sharing, supply chain resilience for medical countermeasures, and the expansion of technical education to include biomanufacturing skills.

The project aims to protect the health of approximately 2.3 million people in Lao PDR by addressing the direct and indirect impacts of climate change on the health sector. It focuses on four key outcomes: strengthening climate-resilient governance and leadership, improving health information systems to include climate and weather data, enhancing health service delivery in rural provinces, and increasing community capacity to respond to early warnings. Key activities include upgrading the infrastructure and WASH services of 79 health facilities to be more resilient and energy-efficient, and providing financial support to 173 communities to implement health and climate resilience action plans. The project is designed as a two-phase approach, with Phase 1 serving as a model for potential nationwide scaling in Phase 2.

The health systems of the Horn of Africa are severely strained by conflict, insecurity, and drought, leading to high rates of malnutrition and maternal and child mortality. While life expectancy has generally increased, the region struggles to meet SDG targets, with a dual burden of persistent communicable diseases and steady rates of non-communicable diseases and injuries.

The Global Climate and Health Alliance (GCHA) and Health and Climate Network (HCN) submit that health is a prerequisite and critical indicator for the Paris Agreement's success. They highlight that mitigation in energy, food, and transport can prevent millions of deaths annually by 2040, yet only 28% of updated NDCs recognize these health co-benefits. While 94% of surveyed countries include health in National Adaptation Plans, funding remains a critical barrier, with only 0.5% of certain multilateral adaptation funds allocated to health-specific projects. The document urges the GST to quantify health impacts as non-economic losses and damages and to monitor the realization of the human right to a healthy environment.

The author advocates for a permanent U.S. strategy of vaccine diplomacy, combining ambitious targets for rapid vaccine development and manufacturing with the diplomatic infrastructure needed for global distribution. The text suggests that maintaining 'warm' infrastructure through annual exercises and supporting organizations like Gavi can prevent future outbreaks from reaching pandemic scale and protect U.S. interests by limiting the emergence of dangerous mutations.

The report analyzes the fragmentation of current biosurveillance systems and proposes a transition to a global early warning ecosystem. It highlights the role of emerging technologies like metagenomic sequencing and CRISPR-based diagnostics in reducing detection timelines. Through regional case studies and historical vignettes of outbreaks like COVID-19, SARS, and Ebola, the document identifies critical gaps in infrastructure, political will, and data interoperability, while providing a roadmap for future investments and diplomatic coordination.

The briefing assesses the critical role of the Chemical and Biological Defense Program (CBDP) in U.S. national security, highlighting its success in developing medical countermeasures for threats like Ebola and swine flu. Despite these capabilities, the authors report a decade-long decline in CBDP funding, which continued during the COVID-19 pandemic. The document recommends doubling the budget to $2 billion in the short term and increasing it to $6.5–$7 billion annually in subsequent years. It advocates for a shift toward 'rapid response platforms,' including nucleic-acid based therapeutics and metagenomic sequencing, while calling for clarified mission authorities to allow CBDP to respond to natural pandemics.

The document argues that the U.S. must address unstable biodefense funding and the tendency to cut budgets during crises. Drawing on the success of Operation Warp Speed, the authors propose a 10-year commitment of $10 billion annually to both the Department of Health and Human Services (HHS) and the Department of Defense (DoD) to counter rising biological threats, including lab accidents and advances in synthetic biology.

SADC member states generally struggle to meet the 2001 Abuja Declaration pledge to allocate 15% of national budgets to healthcare, with an average annual allocation of 5.3%. The COVID-19 pandemic has highlighted critical gaps in healthcare infrastructure, drug supplies, and professional staffing, while simultaneously straining regional economies. To bridge funding gaps amidst declining GDP and high external debt, the paper recommends establishing a SADC regional healthcare fund backed by the African Union, forming public-private partnerships, improving domestic tax compliance, and involving civil society organisations to ensure transparency in health financing.

The author argues that Donald Trump pursued a 'herd immunity' approach to Covid-19 not for epidemiological reasons, but to frame public health measures as Democratic-led attacks on the working class and small business owners. By dismissing scientific expertise and associating mask-wearing with weakness, Trump leveraged the pandemic as a campaign tool to solidify support among his base, particularly the less-educated petite bourgeoisie, by presenting a choice between public health and employment.

The briefing argues that biological weapons remain a viable and rational strategic option for some states due to their low cost, potential for deniability, and asymmetric impact. It challenges the notion that these weapons are tactically useless or too risky to develop, noting that historical precedents and the COVID-19 pandemic demonstrate that leaders may prioritize state status or regime survival over the risks of blowback. The authors further contend that bioweapons programs are not always top-down initiatives and that current international norms, specifically the Biological Weapons Convention, lack the enforcement and verification mechanisms necessary to effectively stop such programs.

The report argues that private equity firms use dividend recapitalizations to extract short-term profits from health care companies by loading them with debt, which can lead to bankruptcy, reduced patient care, and the diversion of public funds. It highlights several case studies where firms paid billions in dividends while facing legal issues or financial decline, and calls for increased transparency and limits on leverage and dividends.

The Council on Strategic Risks identifies a gap between the existing technical capacity for real-time pathogen surveillance and the actual implementation in the United States. While tools like next-generation sequencing and metagenomics enable rapid detection, the U.S. response is hindered by outdated data sharing methods, such as fax machines, and a lack of a trusted, neutral entity to manage global health data. The report advocates for a 'wartime footing' to modernize public health infrastructure and create a coordinated, potentially independent, data-focused institute to manage pathogen information.

The author contends that the Indian government's response to Covid-19 was characterized by a lack of preparedness, the scapegoating of the Muslim community, and a sudden lockdown that stranded millions of migrant workers. The text asserts that the state leveraged the crisis to arrest activists, create a non-transparent relief fund (PM-CARES), and weaken environmental regulations through the Environment Impact Assessment Draft 2020 to favor private capital.

The report details Ghana's response to COVID-19 up to June 23, 2020, highlighting the tension between public health restrictions and economic survival. It describes the strain on health infrastructure, the government's financial interventions, and the socio-economic hardships faced by vulnerable groups and the informal sector. The text also notes the shift in national spending priorities, the local production of medical supplies, and the challenges of maintaining electoral processes during the pandemic.

The policy brief critiques the South African government's 'risk-adjusted' strategy for reopening the economy during the COVID-19 pandemic, arguing that it prioritizes business profitability over worker safety and ignores the impact of deep social inequalities. The authors propose a 'well-being economy' framework that treats health and economic performance as intertwined. Key recommendations include democratizing the return to work through worker oversight, implementing a universal basic income guarantee, expanding social infrastructure in townships, and reversing austerity measures in the national budget to provide a genuine rescue package for the most vulnerable.